DEA AND THEIR CAMPAIGN AGAINST CHRONIC PAIN PATIENTS
By: Jacinto Rivera
Date: June 6, 2016
Audio Version Here
Two years ago the DEA, started a campaign against chronic pain patients when they choose to classified hydrocodone as a schedule II drug. This has placed thousand if not hundreds of thousands of patients like myself and doctors in a stage of alarm.
This information is not to be used on any ways to speak off negatively about Truvada also know as PrEP. This information is to make conscious of the risk involved while using Truvada.
After so many years suffering from the pandemic left by the HIV virus and a number of deaths surpassing millions globally, letting pharmaceutical businesses battling for the reach on finding a cure for the virus which causes AIDS. The GILEAD Sciences Inc. was able to develop Truvada, Also known as PrEP.